These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 20376721)

  • 1. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.
    Trees AJ; Graham SP; Renz A; Bianco AE; Tanya V
    Parasitology; 2000; 120 Suppl():S133-42. PubMed ID: 10874716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applied field research for comprehensive helminth infection control.
    Soboslay PT; Gantin RG; Banla M; Karabou PK; Agossou A; Douti JK; Djassoa G; Heuschkel C; Schulz-Key H; Hamm DM; Stingl P
    Wien Klin Wochenschr; 2010 Mar; 122 Suppl 1():27-30. PubMed ID: 20376721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
    Ndyomugyenyi R; Kabatereine N
    Trop Med Int Health; 2003 Nov; 8(11):997-1004. PubMed ID: 14629766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.
    Hotez PJ; Kamath A
    PLoS Negl Trop Dis; 2009 Aug; 3(8):e412. PubMed ID: 19707588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coinfections with Schistosoma haematobium, Necator americanus, and Entamoeba histolytica/Entamoeba dispar in children: chemokine and cytokine responses and changes after antiparasite treatment.
    Hamm DM; Agossou A; Gantin RG; Kocherscheidt L; Banla M; Dietz K; Soboslay PT
    J Infect Dis; 2009 Jun; 199(11):1583-91. PubMed ID: 19392635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filaria control and elimination: diagnostic, monitoring and surveillance needs.
    Molyneux DH
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):338-41. PubMed ID: 19181357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.
    Hoerauf A; Specht S; Marfo-Debrekyei Y; Büttner M; Debrah AY; Mand S; Batsa L; Brattig N; Konadu P; Bandi C; Fimmers R; Adjei O; Büttner DW
    Parasitol Res; 2009 Jan; 104(2):437-47. PubMed ID: 18850111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of onchocerciasis control in Africa.
    Hodgkin C; Molyneux DH; Abiose A; Philippon B; Reich MR; Remme JH; Thylefors B; Traore M; Grepin K
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e74. PubMed ID: 17989787
    [No Abstract]   [Full Text] [Related]  

  • 14. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.